Wuhan YZY Biopharma Co., Ltd. - B - H Shares Stock: price and insider trades · Hong Kong
1 insider bought €9.5M of shares over the last 90 days, the latest by YUAN QIAN, filed 15 Sept 2026.
Wuhan YZY Biopharma Co., Ltd. - B - H Shares: what insiders have been doing
Wuhan YZY Biopharma Co., Ltd. - B - H Shares is a listed company. Filings by its managers are published through HKEX. The last twelve months, up to 26 October 2026, brought 3 filings signed by 2 insiders.
Every open-market trade in the period is a purchase: 1 purchase worth €9.5M, from 1 insider, and not a single sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Yuan Qian filed the largest purchase, €9.5M, on 15 September 2026. The buyers include 1 senior executive.
The last insider purchase was made public on 15 September 2026, 54 days ago. Filings reach the HKEX feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
For context, the typical company on the same exchange (median of 1,315 companies) published 4 filings over the same period, against 3 filings here. The full history, which starts in 2026, counts 1 purchase against no sales.
This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 35,592,400 shares@ HK$2.43100.0% of flowShareXHKGHKEX:DA20260914E00538Canonical exit: 28 Nov 2026 (T+90)
- 35,592,400 shares@ HK$2.43100.0% of flowShareXHKGHKEX:DA20260914E00537Canonical exit: 28 Nov 2026 (T+90)
- 35,592,400 shares@ HK$2.43100.0% of flowShareXHKGHKEX:DA20260914E00536Canonical exit: 28 Nov 2026 (T+90)
- 1,342,600 sharesShareXHKGHKEX:DA20260616E00173
- 1,342,600 sharesShareXHKGHKEX:DA20260616E00160
5 of 5 declarations
About Wuhan YZY Biopharma Co., Ltd. - B - H Shares
Wuhan YZY Biopharma Co., Ltd. is a biopharmaceutical company that provides innovative solutions for the treatment of various diseases. It is listed under the B category of H shares.